{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:34:34Z","timestamp":1762079674139,"version":"3.37.3"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0209374","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T13:45:22Z","timestamp":1546263922000},"page":"e0209374","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-8192","authenticated-orcid":true,"given":"Beat","family":"M\u00fcllhaupt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Bruggmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Bihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9252-7576","authenticated-orcid":true,"given":"Sarah","family":"Blach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lavanchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homie","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Robbins Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Semela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"e0125214","DOI":"10.1371\/journal.pone.0125214","article-title":"Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland","volume":"10","author":"B Mullhaupt","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00042737-200201000-00006","article-title":"Simulation of hepatitis C based on a mandatory reporting system","volume":"14","author":"M Sagmeister","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jvh.12247","article-title":"Historical epidemiology of hepatitis C virus (HCV) in selected countries","volume":"21","author":"P Bruggmann","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref4","first-page":"w13793","article-title":"Hepatitis B and C in Switzerland\u2014healthcare provider initiated testing for chronic hepatitis B and C infection","volume":"143","author":"R Fretz","year":"2013","journal-title":"Swiss Med Wkly"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"GL Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"S Blach","year":"2017","journal-title":"The Lancet Gastroenterology & Hepatology"},{"year":"2017","author":"C Zahnd","key":"ref7"},{"key":"ref8","unstructured":"Swiss Hepatitis Strategy 2014\u20132030. Time to Act Now! Process Paper\u2014A Living Document. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hepatitis-schweiz.ch\/files\/Dokumente\/Process_Paper_2nd_version_final.pdf\" xlink:type=\"simple\">http:\/\/www.hepatitis-schweiz.ch\/files\/Dokumente\/Process_Paper_2nd_version_final.pdf<\/ext-link>. 2015."},{"key":"ref9","unstructured":"Assembly WHOS-NWH. Global Health Sector Strategies Viral Hepatitis 2016\u20132021. 2016."},{"issue":"Suppl 1","key":"ref10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","article-title":"The present and future disease burden of hepatitis C virus (HCV) infection with today&apos;s treatment paradigm","volume":"21","author":"H Razavi","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref11","article-title":"The epidemiology of hepatitis C in Switzerland: trends in notifcations, 1988\u20132015","volume":"148","author":"J-L Richard","year":"2018","journal-title":"Swiss Med Wkly"},{"key":"ref12","first-page":"w14543","article-title":"Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030","volume":"147","author":"P Bruggmann","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"ref13","unstructured":"Swiss Statistics of Cancer Incidence [Internet]. 2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unige.ch\/medecine\/rgt\/donneessuisses\/\" xlink:type=\"simple\">http:\/\/www.unige.ch\/medecine\/rgt\/donneessuisses\/<\/ext-link>."},{"key":"ref14","first-page":"w14560","article-title":"Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland","volume":"148","author":"J Bachofner","year":"2018","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/liv.13528","article-title":"Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study","volume":"38","author":"C Beguelin","year":"2018","journal-title":"Liver Int"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3109\/10826084.2015.1023451","article-title":"Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy","volume":"50","author":"SC Kalichman","year":"2015","journal-title":"Subst Use Misuse"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jhep.2015.02.044","article-title":"Studies on the epidemiology of hepatitis B and C virus infections are still needed","volume":"62","author":"P. Deltenre","year":"2015","journal-title":"Journal of Hepatology"},{"key":"ref18","article-title":"World Bank to lend Health ministry $200m for hepatitis C screening: minister","volume":"28","author":"H. Omran","year":"2018","journal-title":"Daily News Egypt"},{"key":"ref19","first-page":"w14221","article-title":"Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland","volume":"145","author":"P Bruggmann","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"ref20","first-page":"w14544","article-title":"Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade","volume":"147","author":"A Bregenzer","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"ref21","first-page":"64","article-title":"Managing hepatitis C in general practice","volume":"40","author":"S. Strasser","year":"2017","journal-title":"Aust Prescr"},{"key":"ref22","unstructured":"Estill J, Sadeghimehr M, Keiser O, Bertisch B. Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland; A Comprehensive Mathematical Model of the Swiss HCV Epidemic; Final Report. Institute of Global Health, University of Geneva; 2018."},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2018.05.027","article-title":"Assessing the cost-effectiveness of hepatitis C screening strategies in France","volume":"69","author":"S Deuffic-Burban","year":"2018","journal-title":"J Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0209374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:54:53Z","timestamp":1588971293000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0209374"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0209374","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}